Expectations and Challenges of First-Line Maintenance Therapy for Advanced Ovarian Cancer

The incidence of ovarian cancer, which has had a poor prognosis, is increasing annually. Currently, the prognosis is expected to improve with the use of molecular-targeted drugs and immune checkpoint inhibitors as maintenance therapies after the first-line chemotherapy. The GOG218 and ICON7 studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoji, Tadahiro, Sato, Chie, Tomabechi, Hidetoshi, Takatori, Eriko, Kaido, Yoshitaka, Nagasawa, Takayuki, Kagabu, Masahiro, Baba, Tsukasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155998/
https://www.ncbi.nlm.nih.gov/pubmed/34063455
http://dx.doi.org/10.3390/medicina57050501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155998/
https://www.ncbi.nlm.nih.gov/pubmed/34063455
http://dx.doi.org/10.3390/medicina57050501

Ejemplares similares